Antibe Therapeutics Inc(Pre-Merger) ATBPF

Timeline

[Nick80]

Finally a release with some commitment.

I think we all know this is going to be a longer way to see old valuations again however there is a plan timeline and viable option going forward. 

We hopefully will see some further good news from IPs and other drugs and medical conditions they are going to target to show what the potential value is there.

I rather wait a little longer than having them rushing into it with a suboptimal dose regiment to experience another deja vu.

Lets see what there commercial study brings and maybe some partnering in the longer term since the drug should now be more derisked than it was before, given the short term treatment regiment. 
Curious to see what their loding dose regiment could be anyone of you who can guess ?

[baggerx99]

Your comment of being derisked is very valid......there's enough brain power of clinical and academic advisors to develop a route to success now knowing the action of Otena on the liver, great for them.. My belief is this new approach will be gobbled up by a big pharma at some point........

[Wriggles]

Not much new here on schedule from what was said in the Echelon report October 19.   https://www.cantechletter.com/2021/10/antibe-therapeutics-has-a-159-per-cent-upside-says-echelon/#     "Moving forward, Quenneville notes that the company’s plan for otenaproxesul is to quickly undertake a Phase I study to establish dosing parameters for a loading dose regimen and to